Compare KLXE & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KLXE | MYO |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | United States | United States |
| Employees | 1548 | N/A |
| Industry | Oilfield Services/Equipment | Industrial Specialties |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.1M | 44.8M |
| IPO Year | 2018 | 2017 |
| Metric | KLXE | MYO |
|---|---|---|
| Price | $2.40 | $1.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 226.7K | ★ 901.7K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $636,600,000.00 | ★ $1,000,000,000.00 |
| Revenue This Year | $3.89 | $9.10 |
| Revenue Next Year | $4.95 | $13.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $1.49 | $0.61 |
| 52 Week High | $4.50 | $2.22 |
| Indicator | KLXE | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 41.85 | 48.27 |
| Support Level | $2.09 | $0.69 |
| Resistance Level | $2.58 | $1.17 |
| Average True Range (ATR) | 0.19 | 0.10 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 54.10 | 41.07 |
KLX Energy Services Holdings Inc is a growth-oriented provider of diversified oilfield services to onshore oil and natural gas exploration and production (E&P) companies operating in both conventional and unconventional plays in all of the active basins throughout the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Southwest region.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.